DPW
TEVA icon

DiNuzzo Private Wealth’s Teva Pharmaceuticals TEVA Stock Holding History

DiNuzzo Private Wealth’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63K Hold
48
– – ﹤0.01% 750
2026
Q1 		$1.45K Hold
48
– – ﹤0.01% 761
2025
Q4 		$1.5K Hold
48
– – ﹤0.01% 742
2025
Q3 		$883 Hold
48
– – ﹤0.01% 919
2025
Q2 		$805 Hold
48
– – ﹤0.01% 927
2025
Q1 		$738 Hold
48
– – ﹤0.01% 927
2024
Q4 		$1.06K Buy
+48
New +$873 ﹤0.01% 829

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

DiNuzzo Private Wealth's TEVA Position: Q2 2026 in Review

DiNuzzo Private Wealth held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 48 shares worth $1.63K. The position accounts for ﹤0.01% of the portfolio, ranked #750.

DiNuzzo Private Wealth first reported a position in TEVA in Q4 2024 and has held it in 7 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • DiNuzzo Private Wealth held 48 shares of Teva Pharmaceuticals worth $1.63K as of Q2 2026.
  • DiNuzzo Private Wealth left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #750 holding.
  • DiNuzzo Private Wealth first reported a position in Teva Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.